Luisa M Stamm Selected Research

Ribavirin (Virazole)

1/2019	Comparison of the efficacy of sofosbuvir plus ribavirin in Chinese patients with genotype 3a or 3b HCV infection.
1/2019	Efficacy and safety of sofosbuvir-velpatasvir with or without ribavirin in HCV-infected Japanese patients with decompensated cirrhosis: an open-label phase 3 trial.
10/2018	Efficacy of Sofosbuvir and Velpatasvir, With and Without Ribavirin, in Patients With Hepatitis C Virus Genotype 3 Infection and Cirrhosis.
7/2018	Sofosbuvir-velpatasvir plus ribavirin in Japanese patients with genotype 1 or 2 hepatitis C who failed direct-acting antivirals.
1/2017	Efficacy of Ledipasvir Plus Sofosbuvir for 8 or 12 Weeks in Patients With Hepatitis C Virus Genotype 2 Infection.
1/2017	Sofosbuvir-velpatasvir-voxilaprevir with or without ribavirin in direct-acting antiviral-experienced patients with genotype 1 hepatitis C virus.
11/2016	Efficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients With Genotype 1 Hepatitis C Virus Infection in an Open-Label, Phase 2 Trial.
1/2016	Efficacy of the Combination of Sofosbuvir, Velpatasvir, and the NS3/4A Protease Inhibitor GS-9857 in Treatment-Naïve or Previously Treated Patients With Hepatitis C Virus Genotype 1 or 3 Infections.
1/2016	The safety and efficacy of ledipasvir/sofosbuvir for the treatment of a nosocomial outbreak of HCV in patients with significant cardiovascular disease.
10/2015	Temporal dynamics of inflammatory cytokines/chemokines during sofosbuvir and ribavirin therapy for genotype 2 and 3 hepatitis C infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Luisa M Stamm Research Topics

Disease

23	Infections 04/2024 - 10/2015
14	Fibrosis (Cirrhosis) 11/2022 - 08/2015
9	Chronic Hepatitis C 03/2019 - 11/2016
4	Chronic Hepatitis B 04/2024 - 11/2022
3	Hepatitis C 01/2019 - 10/2015
2	Headache (Headaches) 10/2018 - 01/2017
2	Fatigue 01/2017 - 01/2017
2	Nausea 01/2017 - 01/2017
2	Diarrhea 01/2017 - 01/2017
1	Viremia 01/2022
1	Sepsis (Septicemia) 01/2019
1	Virus Diseases (Viral Diseases) 01/2019
1	Hemorrhage 01/2019
1	Liver Diseases (Liver Disease) 01/2019
1	Esophageal and Gastric Varices (Esophageal Varices) 01/2019
1	Hepatocellular Carcinoma (Hepatoma) 01/2019
1	Sleep Initiation and Maintenance Disorders (Insomnia) 10/2018
1	Asthenia 10/2018
1	Gastroenteritis 01/2017
1	Bronchitis 01/2017
1	Anemia 01/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2016
1	Persistent Infection 01/2015

Drug/Important Bio-Agent (IBA)

16	SofosbuvirIBA 03/2019 - 10/2015
13	velpatasvirIBA 03/2019 - 01/2016
10	Ribavirin (Virazole)FDA LinkGeneric 01/2019 - 10/2015
6	Antiviral Agents (Antivirals)IBA 04/2024 - 01/2016
5	sofosbuvir velpatasvir voxilaprevir drug combinationIBA 01/2019 - 01/2017
5	voxilaprevirIBA 01/2017 - 01/2016
4	TabletsIBA 01/2019 - 01/2017
3	NucleotidesIBA 01/2017 - 11/2016
3	Protease Inhibitors (Protease Inhibitor)IBA 01/2017 - 01/2016
2	DNA (Deoxyribonucleic Acid)IBA 11/2022 - 01/2022
2	InterferonsIBA 01/2016 - 01/2016
1	Biomarkers (Surrogate Marker)IBA 08/2023
1	entecavir FDA Link 11/2022
1	Hepatitis B e AntigensIBA 11/2022
1	Reverse Transcriptase InhibitorsIBA 11/2022
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2019
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2018
1	efavirenz (Sustiva)FDA Link 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	ledipasvirIBA 01/2017
1	VimentinIBA 03/2016
1	sofosbuvir drug combination ledipasvirIBA 01/2016
1	lathosterolIBA 01/2016
1	Drug CombinationsIBA 01/2016
1	ChemokinesIBA 10/2015
1	Alanine Transaminase (SGPT)IBA 10/2015
1	Interleukin-18 (Interleukin 18)IBA 10/2015
1	CytokinesIBA 10/2015
1	RNA (Ribonucleic Acid)IBA 01/2015

Therapy/Procedure

8	Therapeutics 04/2024 - 08/2015
3	Aftercare (After-Treatment) 04/2024 - 01/2018
3	Duration of Therapy 04/2024 - 01/2016
2	Retreatment 08/2023 - 01/2019
1	Investigational Therapies (Experimental Therapy) 08/2023
1	Liver Transplantation 01/2018